ARTICLE | Clinical News
Acapodene toremifene: Extension study started
May 1, 2006 7:00 AM UTC
GTXI began a double-blind, placebo-controlled, U.S. and Mexican Phase IIIb extension study in about 700 patients. The trial is an extension of the 1,400-patient Phase III ADT study. Patients in the Ph...